Tianjin Ringpu Bio-Technology Co.,Ltd. (TIANJIN RINGPU BIO-TECHNOLOGY C) Aktie
300119.SZ
GeschlossenTIANJIN RINGPU BIO-TECHNOLOGY C
Market Cap
$7,222,288,384
Über Tianjin Ringpu Bio-Technology Co.,Ltd. (TIANJIN RINGPU BIO-TECHNOLOGY C) Aktie
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and poultry, waterfowl, livestock, rumination, pets, washing and disinfection, active pharmaceutical ingredients product series. It also offers diagnosis and treatment services, such as epidemic diagnosis and testing, animal drug evaluation, and veterinary socialization. The company was founded in 1998 and is headquartered in Tianjin, China.
Unternehmensinformationen
300308 Tianjin, China
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.